presentations
Comparison of fluorescein angiographic evaluation of the lesion size of choroidal neovascularization associated with age-related macular degeneration in participants and non-participants of the home tele-monitoring study (ForeseeHome Study)
Ramiro S. Maldonado, Elvira Agron, Traci E. Clemons, Emily Y. ChewHome telemonitoring device strategy resulted in smaller lesions of CNV than the other two groups. This early detection was associated with better visual acuity and may represent better visual outcomes following therapy for participants in the telemonitoring group.
FDA Intended Use
ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.
